Home » Reports » Broker Ratings » Oxford BioMedica plc 14.5% Potential Upside Indicated by Jefferies International
broker ratings

Oxford BioMedica plc 14.5% Potential Upside Indicated by Jefferies International

Oxford BioMedica plc using EPIC/TICKER code (LON:OXB) has had its stock rating noted as ‘Downgrades’ with the recommendation being set at ‘HOLD’ this morning by analysts at Jefferies International. Oxford BioMedica plc are listed in the Health Care sector within UK Main Market. Jefferies International have set their target price at 1100 GBX on its stock. This indicates the analyst now believes there is a potential upside of 14.5% from the opening price of 961.1 GBX. Over the last 30 and 90 trading days the company share price has increased 243.1 points and increased 356.1 points respectively. The 52 week high share price is 1032.4 GBX while the 52 week low is 262.5 GBX.

Oxford BioMedica plc has a 50 day moving average of 691.88 GBX and a 200 Day Moving Average share price is recorded at 551.63. There are currently 64,915,161 shares in issue with the average daily volume traded being 291,027. Market capitalisation for LON:OXB is £637,317,589 GBP.